Supernus Pharmaceuticals, Inc. (SUPN)
48.33
-1.10
(-2.23%)
USD |
NASDAQ |
May 18, 16:00
47.93
-0.40
(-0.83%)
After-Hours: 06:50
Supernus Pharmaceuticals Total Assets (Quarterly) : 1.501B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 814.88M |
| Johnson & Johnson | 200.89B |
| Amphastar Pharmaceuticals, Inc. | 1.648B |
| Assertio Holdings, Inc. | 211.30M |
| Eli Lilly & Co. | 116.58B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 423.92M |
| Shareholders Equity (Quarterly) | 1.077B |
| Debt to Equity Ratio | 0.038 |
| Current Ratio | 1.956 |
| Net Debt Paydown Yield | -0.04% |